TY  - RPRT
TI  - Molecular evaluation of residual disease following neoadjuvant chemotherapy in triple-negative breast cancer CALGB 40603 (Alliance).
AU  - Patrick D Rädler
AU  - Brooke M Felsheim
AU  - Aranzazu Fernandez-Martinez
AU  - Adam D Pfefferle
AU  - Michele C Hayward
AU  - Baljit Singh
AU  - William Sikov
AU  - Lisa A Carey
AU  - Charles M Perou
PY  - 2026
DO  - 10.1172/jci205962
UR  - https://pubmed.ncbi.nlm.nih.gov/42550611/
ID  - 42550611
ER  -